TB-500 (Thymosin Beta-4) 5mgTB-500 (Thymosin Beta-4) 5mg
A thymosin beta-4-associated product whose identity and human evidence must not be assumed from its marketing name.
Answer a short online consultation. A clinician reviews it, and you only pay if treatment is approved. Dispensed by our licensed facility.
What it is
Thymosin beta-4 is a naturally occurring 43-amino-acid protein involved in binding actin inside cells. TB-500 is a commercial label used inconsistently for thymosin-related material, including fragments.
Actin regulation can influence cell movement and tissue responses. Findings for full-length thymosin beta-4 cannot automatically be assigned to a vial labelled TB-500 without verified molecular identity.
Why people ask about it
People enquire about soft-tissue recovery, often after seeing results for a different thymosin molecule or a topical preparation.
What the science says
Published thymosin beta-4 work includes preclinical studies and small human investigations of specific topical formulations, including corneal and skin applications. This does not establish the effectiveness or safety of injectable TB-500 for musculoskeletal recovery.
Is it right for me?
TB-500 requires an online consultation and clinician approval before payment, including review of the exact substance and whether a clinically defensible option exists.
How Welcuren works
Complete a short online consultation about your health and goals.
A clinician reviews your answers, may ask follow-up questions, and decides whether this treatment is appropriate for you.
You only pay once treatment is approved. Our licensed facility then dispatches it with full instructions, on tracked global delivery.
Safety
Product identity, sterility and immune reactions are major uncertainties, while long-term systemic safety is not established. Pregnancy, breastfeeding and a history of cancer merit particular scrutiny because of limited data and growth-related signalling; your clinician will advise
Questions
Are TB-500 and thymosin beta-4 always identical?
No: suppliers use TB-500 inconsistently, so the sequence and analytical identity matter.
Do eye-drop studies support injectable TB-500?
Evidence from an ophthalmic formulation cannot validate a systemic product for an unrelated goal.
Why is actin mentioned in TB-500 descriptions?
Full-length thymosin beta-4 binds actin, a structural protein involved in cell movement.
Can athletes use TB-500?
Thymosin beta-4 and its derivatives, including TB-500, are prohibited by the World Anti-Doping Agency.
This information is educational and not a substitute for advice from your clinician. Prescription treatments are only supplied after a clinical consultation.
Often considered together
Many clients start with a blood test so their clinician has a full picture.
ARA-290 (Cibinetide) 10mgARA-290 (Cibinetide) 10mg
ARA-290 (Cibinetide) 10mg is an investigational erythropoietin-derived peptide, considered only after online consultation and clinician approval.
BPC-157 + TB-500 Blend 10mgBPC-157 + TB-500 Blend 10mg
A two-component blend without controlled human evidence that the combination improves recovery or offers added benefit.
BPC-157 5mgBPC-157 5mg
A synthetic 15-amino-acid peptide with predominantly rodent evidence and no established clinical benefit for injury recovery.